1. Home
  2. SLNO vs WFRD Comparison

SLNO vs WFRD Comparison

Compare SLNO & WFRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • WFRD
  • Stock Information
  • Founded
  • SLNO 1999
  • WFRD 1941
  • Country
  • SLNO United States
  • WFRD United States
  • Employees
  • SLNO N/A
  • WFRD N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • WFRD Metal Fabrications
  • Sector
  • SLNO Health Care
  • WFRD Industrials
  • Exchange
  • SLNO Nasdaq
  • WFRD Nasdaq
  • Market Cap
  • SLNO 3.8B
  • WFRD 4.1B
  • IPO Year
  • SLNO 2014
  • WFRD N/A
  • Fundamental
  • Price
  • SLNO $62.37
  • WFRD $65.34
  • Analyst Decision
  • SLNO Strong Buy
  • WFRD Strong Buy
  • Analyst Count
  • SLNO 9
  • WFRD 7
  • Target Price
  • SLNO $116.78
  • WFRD $92.71
  • AVG Volume (30 Days)
  • SLNO 2.7M
  • WFRD 798.9K
  • Earning Date
  • SLNO 11-05-2025
  • WFRD 10-21-2025
  • Dividend Yield
  • SLNO N/A
  • WFRD 1.53%
  • EPS Growth
  • SLNO N/A
  • WFRD N/A
  • EPS
  • SLNO N/A
  • WFRD 6.50
  • Revenue
  • SLNO $32,656,999.00
  • WFRD $5,147,000,000.00
  • Revenue This Year
  • SLNO N/A
  • WFRD N/A
  • Revenue Next Year
  • SLNO $181.85
  • WFRD N/A
  • P/E Ratio
  • SLNO N/A
  • WFRD $10.07
  • Revenue Growth
  • SLNO N/A
  • WFRD N/A
  • 52 Week Low
  • SLNO $41.50
  • WFRD $36.74
  • 52 Week High
  • SLNO $90.32
  • WFRD $95.58
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 48.83
  • WFRD 52.56
  • Support Level
  • SLNO $55.78
  • WFRD $65.01
  • Resistance Level
  • SLNO $68.46
  • WFRD $70.06
  • Average True Range (ATR)
  • SLNO 4.12
  • WFRD 2.55
  • MACD
  • SLNO 0.71
  • WFRD -0.52
  • Stochastic Oscillator
  • SLNO 67.58
  • WFRD 37.32

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About WFRD Weatherford International plc

Weatherford International provides diversified oilfield services across international markets for an array of oilfield types. The firm is a global market leader in artificial lift and tubular running services. Other key product lines include cementing products, directional drilling, and wireline evaluation.

Share on Social Networks: